The antidiabetic agent rosiglitazone upregulates SERCA2 and enhances TNF-alpha- and LPS-induced NF-kappaB-dependent transcription and TNF-alpha-induced IL-6 secretion in ventricular myocytes. [electronic resource]
Producer: 20050804Description: 41-50 p. digitalISSN:- 1015-8987
- Animals
- Animals, Newborn
- Calcium -- metabolism
- Calcium Signaling -- drug effects
- Calcium-Transporting ATPases -- metabolism
- Cells, Cultured
- Enzyme Induction -- drug effects
- Heart Ventricles -- drug effects
- Hypoglycemic Agents -- pharmacology
- Interleukin-6 -- metabolism
- Lipopolysaccharides -- pharmacology
- Luciferases -- metabolism
- Muscle Cells -- cytology
- NF-kappa B -- metabolism
- Rats
- Rats, Sprague-Dawley
- Rosiglitazone
- Sarcoplasmic Reticulum Calcium-Transporting ATPases
- Thiazolidinediones -- pharmacology
- Transcription Factor RelA
- Transcription, Genetic -- drug effects
- Tumor Necrosis Factor-alpha -- pharmacology
- beta-Galactosidase -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.